| http://dbpedia.org/ontology/abstract
|
Relugolix, sold under the brand names Orgo … Relugolix, sold under the brand names Orgovyx and Relumina and as one component of Myfembree, is a gonadotropin-releasing hormone antagonist (GnRH receptor antagonist) medication which is used in the treatment of prostate cancer in men and uterine fibroids in women. It is also under development for use in the treatment of endometriosis. It is taken by mouth once per day. Side effects of relugolix include menstrual abnormalities, hot flashes, excessive sweating, headache, and decreased bone mineral density. Relugolix is a GnRH antagonist, or an antagonist of the gonadotropin-releasing hormone receptor. Unlike most other GnRH modulators, but similarly to elagolix (brand name Orilissa), relugolix is a non-peptide, small-molecule compound and is orally active. It suppresses sex hormone levels to the postmenopausal or castrate range in both women and men with administration once per day. As of February 2019, relugolix is in phase III clinical trials for endometriosis. It was approved for use for the treatment of uterine fibroids in Japan in January 2019, and for the treatment of prostate cancer in the United States in December 2020.cer in the United States in December 2020.
, Relugolix ist ein Arzneistoff zur Behandlu … Relugolix ist ein Arzneistoff zur Behandlung von bösartigen Tumoren (Krebs), die hormonempfindlich sind. Er wird angewendet zur Behandlung des fortgeschrittenen Prostatakrebses. Er kommt ferner zum Einsatz zur Linderung von mäßigen bis starken Symptomen bei Gebärmuttermyomen und experimentell bei Endometriose, einer Erkrankung, bei der gebärmutterschleimhautartiges Gewebe außerhalb der Gebärmutterhöhle vorkommt. Relugolix wirkt als und kann oral gegeben (eingenommen) werden.nd kann oral gegeben (eingenommen) werden.
|
| http://dbpedia.org/ontology/alternativeName
|
Orgovyx, Relumina
|
| http://dbpedia.org/ontology/atcCode
|
(combination withestradiolandnorethisterone)
|
| http://dbpedia.org/ontology/casNumber
|
737789-87-6
|
| http://dbpedia.org/ontology/chEMBL
|
1800159
|
| http://dbpedia.org/ontology/class
|
http://dbpedia.org/resource/GnRH_antagonist +
|
| http://dbpedia.org/ontology/drugbank
|
DB11853
|
| http://dbpedia.org/ontology/fdaUniiCode
|
P76B05O5V6
|
| http://dbpedia.org/ontology/kegg
|
D10888
|
| http://dbpedia.org/ontology/pubchem
|
10348973
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Relugolix_structure.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://druginfo.nlm.nih.gov/drugportal/name/relugolix +
|
| http://dbpedia.org/ontology/wikiPageID
|
48188195
|
| http://dbpedia.org/ontology/wikiPageLength
|
22350
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1082623023
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Absorption_%28pharmacokinetics%29 +
, http://dbpedia.org/resource/Category:Ureas +
, http://dbpedia.org/resource/Urine +
, http://dbpedia.org/resource/Postmenopause +
, http://dbpedia.org/resource/Feces +
, http://dbpedia.org/resource/Small-molecule +
, http://dbpedia.org/resource/Uterine_fibroid +
, http://dbpedia.org/resource/Osteoporosis +
, http://dbpedia.org/resource/Category:Pyrimidines +
, http://dbpedia.org/resource/Distribution_%28pharmacology%29 +
, http://dbpedia.org/resource/GnRH_antagonist +
, http://dbpedia.org/resource/Category:Fluoroarenes +
, http://dbpedia.org/resource/Testosterone +
, http://dbpedia.org/resource/Progesterone +
, http://dbpedia.org/resource/Menorrhagia +
, http://dbpedia.org/resource/Bioavailability +
, http://dbpedia.org/resource/Sex_hormone +
, http://dbpedia.org/resource/CYP3A4 +
, http://dbpedia.org/resource/Hyperhidrosis +
, http://dbpedia.org/resource/Hot_flash +
, http://dbpedia.org/resource/Binding_selectivity +
, http://dbpedia.org/resource/Menstrual_abnormalities +
, http://dbpedia.org/resource/Menopause +
, http://dbpedia.org/resource/Norethindrone +
, http://dbpedia.org/resource/Estradiol +
, http://dbpedia.org/resource/Plasma_protein_binding +
, http://dbpedia.org/resource/Interindividual_variability +
, http://dbpedia.org/resource/Luteinizing_hormone +
, http://dbpedia.org/resource/Norethisterone +
, http://dbpedia.org/resource/File:Estradiol_levels_with_40_mg_per_day_oral_relguolix_therapy_in_premenopausal_women.png +
, http://dbpedia.org/resource/Steady-state_levels +
, http://dbpedia.org/resource/Oral_administration +
, http://dbpedia.org/resource/Endometriosis +
, http://dbpedia.org/resource/Substrate_%28biochemistry%29 +
, http://dbpedia.org/resource/Committee_for_Medicinal_Products_for_Human_Use +
, http://dbpedia.org/resource/Category:Hormonal_antineoplastic_drugs +
, http://dbpedia.org/resource/Myovant_Sciences +
, http://dbpedia.org/resource/Gonadotropin-releasing_hormone_antagonist +
, http://dbpedia.org/resource/Tablet_%28pharmacy%29 +
, http://dbpedia.org/resource/Takeda_Pharmaceutical_Company +
, http://dbpedia.org/resource/P-glycoprotein +
, http://dbpedia.org/resource/Generic_term +
, http://dbpedia.org/resource/Category:GnRH_antagonists +
, http://dbpedia.org/resource/European_Medicines_Agency +
, http://dbpedia.org/resource/Headache +
, http://dbpedia.org/resource/Category:Triketones +
, http://dbpedia.org/resource/Cmax_%28pharmacology%29 +
, http://dbpedia.org/resource/Excretion +
, http://dbpedia.org/resource/Clinical_trial +
, http://dbpedia.org/resource/Castration +
, http://dbpedia.org/resource/Urea +
, http://dbpedia.org/resource/Loading_dose +
, http://dbpedia.org/resource/Follicle-stimulating_hormone +
, http://dbpedia.org/resource/Abnormal_uterine_bleeding +
, http://dbpedia.org/resource/Half-maximal_inhibitory_concentration +
, http://dbpedia.org/resource/Category:Pyridazines +
, http://dbpedia.org/resource/Sufugolix +
, http://dbpedia.org/resource/Category:Dimethylamino_compounds +
, http://dbpedia.org/resource/GnRH_modulator +
, http://dbpedia.org/resource/Phenyl_group +
, http://dbpedia.org/resource/Prostate_cancer +
, http://dbpedia.org/resource/Elimination_half-life +
, http://dbpedia.org/resource/Elagolix +
, http://dbpedia.org/resource/Menopausal_symptoms +
, http://dbpedia.org/resource/Estrogen_deficiency +
, http://dbpedia.org/resource/GnRH_analogue +
, http://dbpedia.org/resource/Ethinyl_estradiol +
, http://dbpedia.org/resource/Chemical_compound +
, http://dbpedia.org/resource/Category:Ethers +
, http://dbpedia.org/resource/Hot_flush +
, http://dbpedia.org/resource/Phases_of_clinical_research +
, http://dbpedia.org/resource/Side_effect +
, http://dbpedia.org/resource/Non-peptide +
, http://dbpedia.org/resource/Receptor_antagonist +
, http://dbpedia.org/resource/Chemical_derivative +
, http://dbpedia.org/resource/Gonadotropin-releasing_hormone_receptor +
|
| http://dbpedia.org/property/atcPrefix
|
L02
|
| http://dbpedia.org/property/atcSuffix
|
BX04
|
| http://dbpedia.org/property/c
|
29
|
| http://dbpedia.org/property/casNumber
|
737789
|
| http://dbpedia.org/property/chembl
|
1800159
|
| http://dbpedia.org/property/chemspiderid
|
8524431
|
| http://dbpedia.org/property/class
|
http://dbpedia.org/resource/GnRH_antagonist +
|
| http://dbpedia.org/property/dailymedid
|
Relugolix
|
| http://dbpedia.org/property/drugbank
|
DB11853
|
| http://dbpedia.org/property/eliminationHalfLife
|
234000.0
|
| http://dbpedia.org/property/excretion
|
Feces: 82%
, Urine: 4%
|
| http://dbpedia.org/property/f
|
2
|
| http://dbpedia.org/property/h
|
27
|
| http://dbpedia.org/property/image
|
Relugolix molecule ball.png
|
| http://dbpedia.org/property/iupacName
|
1
|
| http://dbpedia.org/property/iupharLigand
|
5586
|
| http://dbpedia.org/property/kegg
|
D10888
|
| http://dbpedia.org/property/legalUs
|
Rx-only
|
| http://dbpedia.org/property/n
|
7
|
| http://dbpedia.org/property/o
|
5
|
| http://dbpedia.org/property/proteinBound
|
68
|
| http://dbpedia.org/property/pubchem
|
10348973
|
| http://dbpedia.org/property/routesOfAdministration
|
http://dbpedia.org/resource/Oral_administration +
|
| http://dbpedia.org/property/s
|
1
|
| http://dbpedia.org/property/smiles
|
CONCNc1ccccc1
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
AOMXMOCNKJTRQP-UHFFFAOYSA-N
|
| http://dbpedia.org/property/synonyms
|
RGX; RVT-601; TAK-385
|
| http://dbpedia.org/property/tradename
|
Orgovyx, Relumina
|
| http://dbpedia.org/property/unii
|
P76B05O5V6
|
| http://dbpedia.org/property/width
|
250
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Cite_web +
, http://dbpedia.org/resource/Template:ClinicalTrialsGov +
, http://dbpedia.org/resource/Template:GnRH_and_gonadotropin_receptor_modulators +
, http://dbpedia.org/resource/Template:GnRH_and_gonadotropins +
, http://dbpedia.org/resource/Template:Portal_bar +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Pituitary_and_hypothalamic_hormones_and_analogues +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Abbrlink +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Cite_journal +
, http://dbpedia.org/resource/Template:ATC +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Dimethylamino_compounds +
, http://dbpedia.org/resource/Category:Pyrimidines +
, http://dbpedia.org/resource/Category:Triketones +
, http://dbpedia.org/resource/Category:Pyridazines +
, http://dbpedia.org/resource/Category:Hormonal_antineoplastic_drugs +
, http://dbpedia.org/resource/Category:Ethers +
, http://dbpedia.org/resource/Category:Ureas +
, http://dbpedia.org/resource/Category:GnRH_antagonists +
, http://dbpedia.org/resource/Category:Fluoroarenes +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Antagonist +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Relugolix?oldid=1082623023&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Estradiol_levels_with_40_mg_per_day_oral_relguolix_therapy_in_premenopausal_women.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Relugolix_molecule_ball.png +
, http://commons.wikimedia.org/wiki/Special:FilePath/Relugolix_structure.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Relugolix +
|
| owl:sameAs |
http://yago-knowledge.org/resource/Relugolix +
, http://de.dbpedia.org/resource/Relugolix +
, http://www.wikidata.org/entity/Q21099000 +
, http://dbpedia.org/resource/Relugolix +
, http://fa.dbpedia.org/resource/%D8%B1%D9%84%D9%88%DA%AF%D9%88%D9%84%DB%8C%DA%A9%D8%B3 +
, https://global.dbpedia.org/id/zT3n +
|
| rdf:type |
http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://www.wikidata.org/entity/Q8386 +
|
| rdfs:comment |
Relugolix, sold under the brand names Orgo … Relugolix, sold under the brand names Orgovyx and Relumina and as one component of Myfembree, is a gonadotropin-releasing hormone antagonist (GnRH receptor antagonist) medication which is used in the treatment of prostate cancer in men and uterine fibroids in women. It is also under development for use in the treatment of endometriosis. It is taken by mouth once per day.riosis. It is taken by mouth once per day.
, Relugolix ist ein Arzneistoff zur Behandlu … Relugolix ist ein Arzneistoff zur Behandlung von bösartigen Tumoren (Krebs), die hormonempfindlich sind. Er wird angewendet zur Behandlung des fortgeschrittenen Prostatakrebses. Er kommt ferner zum Einsatz zur Linderung von mäßigen bis starken Symptomen bei Gebärmuttermyomen und experimentell bei Endometriose, einer Erkrankung, bei der gebärmutterschleimhautartiges Gewebe außerhalb der Gebärmutterhöhle vorkommt. Relugolix wirkt als und kann oral gegeben (eingenommen) werden.nd kann oral gegeben (eingenommen) werden.
|
| rdfs:label |
Relugolix
|
